- Home
- PCRX vs OLP Comparison
PCRX vs OLP Comparison
Compare PCRX & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- OLP
- Stock Information
- Founded
- PCRX 2006
- OLP 1982
- Country
- PCRX United States
- OLP United States
- Employees
- PCRX N/A
- OLP N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- OLP Real Estate Investment Trusts
- Sector
- PCRX Health Care
- OLP Real Estate
- Exchange
- PCRX Nasdaq
- OLP Nasdaq
- Market Cap
- PCRX 604.7M
- OLP N/A
- IPO Year
- PCRX 2011
- OLP N/A
- Fundamental
- Price
- PCRX $22.81
- OLP $25.56
- Analyst Decision
- PCRX Buy
- OLP Strong Buy
- Analyst Count
- PCRX 10
- OLP 1
- Target Price
- PCRX $27.60
- OLP $28.00
- AVG Volume (30 Days)
- PCRX 787.3K
- OLP 63.9K
- Earning Date
- PCRX 02-27-2025
- OLP 03-04-2025
- Dividend Yield
- PCRX N/A
- OLP 6.94%
- EPS Growth
- PCRX N/A
- OLP 51.11
- EPS
- PCRX N/A
- OLP 1.63
- Revenue
- PCRX $694,957,000.00
- OLP $89,142,000.00
- Revenue This Year
- PCRX $4.83
- OLP N/A
- Revenue Next Year
- PCRX $2.16
- OLP $4.71
- P/E Ratio
- PCRX N/A
- OLP $15.80
- Revenue Growth
- PCRX 4.40
- OLP N/A
- 52 Week Low
- PCRX $11.16
- OLP $19.25
- 52 Week High
- PCRX $34.01
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- PCRX 71.48
- OLP 38.99
- Support Level
- PCRX $18.18
- OLP $25.59
- Resistance Level
- PCRX $22.88
- OLP $26.25
- Average True Range (ATR)
- PCRX 1.14
- OLP 0.56
- MACD
- PCRX 0.32
- OLP 0.03
- Stochastic Oscillator
- PCRX 96.36
- OLP 33.69
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.